https://www.businesswire.com/news/home/20240919922998/en/Sparrow-Pharmaceuticals-Presented-New-Data-on-Clofutriben-and-Prednisolone-for-Polymyalgia-Rheumatica-Treatment-at-DGRh-Kongress-2024
Sparrow Pharmaceuticals Presented New Data on Clofutriben and Prednisolone for Polymyalgia...
Sparrow Pharmaceuticals today announced that it presented new data from its ongoing Phase 2 clinical trial of its HSD-1 inhibitor, clofutriben (referred to S...
new datasparrowpharmaceuticalspresented